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Assessment of respiratory function: influence 
of spirometry reference values and normality 
criteria selection 
S. QUADRELLI, A. RONCORONI AND G. MONTIEL 
Seccidn Neumonologia, Institute de Investigaciones Mbdicas Alfiedo Lunari, Universidad de Buenos Aires, 
Argentina 
The purpose of this study was to determine the impact upon classification of patients of the choice of reference 
equation and the criterion defining the lower limit of the normal range in clinical practice. 
One thousand consecutive spirometries were checked to calculate the predicted values [forced vital capacity 
(FVC) and forced expiratory volume in set (FEV,)] in accordance with the equations by Morris, Chemiack, Crapo, 
Knudson and the Economic Community for Coal and Steel (ECCS). We quantified the difference between the 
predicted values obtained for each individual and each equation, determined the percentage of individuals whose 
classification might have changed from normal to abnormal when using a different equation and defined the lower 
limit of the normal range in accordance with the determination of 1. the 90% confidence interval or 2. 80% of 
predicted, comparing their differences. 
The greatest differences found were between the values given by Morris and Crapo’s equations for male FEVr, 
between Morris and Chemiak for female FEVt and male FVC and between Morris and Knudson for female FVC. 
Using 80% of predicted value for female FEVt, up to 35% of tests changed their classification from ‘normal’ to 
‘abnormal’ upon changing the equation used. A high percentage of tests showed a lower limit of normal defined by 
the confidence interval under 80% and 70% of predicted value. 
This study emphasizes the importance of choosing the appropriate reference equation. We do not consider it 
acceptable to use a fixed percentage of the predicted value as the lower limit of normal because of the great number 
of patients found to be inappropriately classified. 
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Introduction 
Data obtained from spirometric measurements taken in 
order to define ‘normality’ or ‘abnormality’ acquire clinical 
meaning when compared to the predicted values. The 
definition of normality (i.e. inclusion into the reference 
values) will depend on two factors; 1. the selected predicted 
values and 2. the criteria used to define the lower limit of 
normal in relation to those predicted values. While 
‘normality’ in pulmonary function tests is simply a 
statistical concept, meaning that one particular value fits 
into the range of reference values, the definition of this 
‘reference range’ still acquires clinical importance. 
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Many pulmonary laboratories tend to define the lower 
limit of normal as 80% of the predicted value. However, 
there is enough theoretical evidence to suggest that this is 
not a valid method and that the normality range should 
instead be established by more rational statistical proce- 
dures (i.e. determination of the fifth percentile or of the 
90% confidence interval using the equation predicted value 
f 1.64 standard error of the estimate). 
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Several reference equations for measuring lung function 
have been published in the last 30 years. Some have been 
derived from specific groups such as laboratory staff, 
workers in certain industries, school populations or non- 
respiratory outpatients (1,2). Some result from epidemio- 
logical studies undertaken for other purposes (3-6) and 
others from studies specifically undertaken to create a 
predicting equation (7-9). The structure of these equations 
varies according to age, ethnic group, the presence or 
absence of smokers, urban or rural populations and the 
height of residence above sea level. The reference values 
obtained are therefore quantitatively different. 
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These considerations acquire practical importance if 
the difference in the definition of normality is frequent 
or large. The purpose of this study was to determine the real 
influence upon the classification of subjects as ‘normal 
or ‘abnormal’ in daily clinical practice produced by 1. 
the choice of a certain reference equation and 2. the 
selection of the criterion to define the lower limit of the 
normal range. 
Material and methods 
One thousand spirometric examinations (500 men and 500 
women) performed at our pulmonary laboratory were 
retrospectively studied. All patients attending were con- 
secutively included, unselected, as our aim was to analyse a 
random clinical population using the existing equations and 
not to construct a new reference equation. We did not, 
therefore, analyse the clinical characteristics of the subjects 
but considered only their anthropometric data in order to 
calculate predicted values using the different equations and 
to show whether they were classified differently (normal or 
abnormal) by the different equations. In order to recalcu- 
late the corresponding predicted values [forced vital 
capacity (FVC) and forced expiratory volume in 1 s 
(FEVi)] in accordance with the equations by Morris (9), 
Cherniack (lo), Crapo (1 l), Knudson (5) and the Economic 
Community for Coal and Steel (ECCS) (4), the age, sex and 
height of the studied individuals were used. All spirometric 
studies were performed by the same well-trained technician 
with a bellow spirometer (Vitalograph, London, UK) 
calibrated daily with a 3-l syringe. During the tests the 
individuals were observed in order to detect cough or 
wheezing. Each test was carried out three times and the 
curve with the best FVC+FEVi value was chosen. The tests 
had to comply with the American Thoracic Society (ATS) 
criteria. The lung volumes were corrected to body 
temperature standard pressure saturated (BTPS). Indivi- 
dual tests which were deemed unsatisfactory were not 
included. Clinical data on patients were not considered. The 
FVC and FEVi values obtained using each equation are 
shown in Tables 1 and 2. 
The information obtained was used as follows. 1. To 
quantify the differences between the predicted values 
obtained for each individual using each equation of 
prediction. The predicted values for each subject were 
obtained from each equation. We then compared the 
obtained predicted values for each subject and from each 
equation with the predicted value obtained from Morris’s 
equation (as it is the most commonly used). We calculated 
the mean differences (d) and the standard deviation of the 
differences (SD) to estimate the limits of agreement (12). 
We therefore obtained the individual difference for each 
of the 1000 tests (predicted value obtained-predicted value 
from Morris’s equation) and established the mean of 
those values. Limits of agreement were determined as 
d+2sn. 
2. To define the lower limit of normal (using the 
predicted values obtained from Morris and Crapo’s 
equations) in accordance with 1. the 90% confidence 
interval obtained using the formula predicted value 
- 1.64 standard error of the estimate (SEE) (the SEE value 
is provided for each equation) and 2. 80% of predicted 
value. 
3. To determine the percentage of individuals whose 
clinical category may have changed (from normal to 
abnormal) due to the equation used (taking the criterion 
of normality as 80% of predicted). For example, we 
calculated the percentage of patients who were above 
80% of the predicted value using their corresponding value 
obtained from Morris’s equation, but under 80% of the 
corresponding value from the equation being tested. The 
same procedure was also used to compare each equation 
against Knudson’s equation and against Knudson’s and the 
ECCS equations for FVC. 
4. To determine the percentage of individuals whose 
clinical category may have changed (from normal to 
abnormal) due to the equation used (taking the criterion 
of normality as the 90% confidence interval). For example, 
we calculated the percentage of patients who were above 
the lower limit of the normal range determined by the 90% 
confidence interval of the predicted value obtained from 
Morris’s equation, but under the limit using the 90% 
confidence interval calculated by the equation being tested. 
The Cherniak equation was not evaluated using this 
method as SEE and residual standard deviation (RSD) 
values are not provided. The same method was used to 
compare Knudson’s equation and the ECCS equations for 
FVC. 
5. To compare the definitions of normality using both 
methods. We calculated the percentage of patients who fell 
into the reference range when using the 90% confidence 
interval but below the reference range using 80% of 
predicted value as the criterion for lower limit of normal. 
THE REFERENCE EQUATIONS SELECTED 
We decided to include some of the most commonly used 
reference equations in the analysis. The criteria upon which 
those equations are based have a major influence on so- 
called ‘normal’ values and the width of the standard 
deviation, and so the backgrounds to the selected reference 
equations are presented here. 
The Morris equation (9) was obtained from a sample of 
988 non-smoking subjects between 20 and 84 years of age. 
They lived in Oregon at less than 500 feet above sea level in 
an area considered relatively free of significant urban air 
pollution. Inclusion criteria were: had not smoked for 
longer than 6 months, never had asthma, chronic bronchitis 
or pneumonia, never had persistent cough, had not been 
treated recently for any respiratory condition, never had 
persistent chest wheezing, never had chest injury or 
operation, never worked in a polluted atmosphere for any 
extended period. Most of the tests were performed between 
1900 and 0900 hours with two Stead-Wells spirometers. 
The Crapo equation (11) was obtained from a sample of 
251 non-smoking subjects of between 15 and 91 years 
of age. They lived in Salt Lake City, Utah, at 1400 m 
above sea level. The magnitude of regional urban air 
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REFERENCE VALUES AND NORMALlTY DEFINITION 527 
pollution was not defined. Inclusion criteria were: lifetime 
non-smoker (total smoking less than 0*5 packs per year and 
no smoking in the previous 6 months), no symptoms of 
lung, heart or chest wall disease, normal chest radiograph, 
normal physical examination of the heart, lungs and chest 
wall. All the tests were performed between 1600 and 2100 
hours with a water-seal metal bell spirometer. 
The Knudson equation (5) was obtained from a sample 
of 746 non-Mexican-American white non-smoking subjects 
of between 8 and 90 years of age. They lived in Tucson, 
Arizona. Inclusion criteria were: able to fill an ‘extensive, 
detailed, self-administered questionnaire’ which defined the 
subject as ‘normal’. Defined requirements were: to be 
totally free of respiratory symptoms or disease, with no 
history of heart trouble or of childhood respiratory 
problems and not to be pregnant. Subjects were stratified 
by age of head of household and socioeconomic status. The 
tests were performed at a non-specified time of day 
recording flow at the mouth with a pneumotachygraph 
device designated for the study. 
The ECCS equation (4) is a summary equation derived 
for Caucasian men and women aged 25-70 years. A review 
of the European literature was performed by a Working 
Party to retrieve information about all the published 
reference equations in the last three decades. For each of 
the regression equations a set of reference values was 
computed for each combination of age and height. The 
computations were performed at 5-cm and 5-year intervals. 
The summary equations, as well as the average residual 
standard deviations, were calculated without weighting for 
numbers of subjects. Thus, the summary equations describe 
an overall mean of data in the literature. 
The characteristics of each equation and the predicted 
values derived from these different equations are shown in 
Tables 3 and 4. 
Results 
COMPARING DIFFERENT REFERENCE 
EQUATIONS 
The theoretical reference values calculated for each subject 
from the Chemiack, Knudson, Crapo and ECCS equations 
were compared with those obtained from the Morris 
equation for each subject. The limits of agreement (applied 
to the whole population) are shown in Table 5. There are 
important differences between the predicted values ob- 
tained by the different equations, especially for male FEVi 
in which, for example, the limits of agreement are as high as 
800 ml for the Morris and Crapo equations or 570 ml for 
the Morris/Knudson equations. There are also important 
differences for female FEVi (maximum difference: Morris 
and Cherniack, 500 ml) and for both male (maximum 
difference: Morris and Cherniack, 430 ml) and female 
(maximum difference: Morris and Knudson, 750 ml) FVC. 
The differences between each pair of equations were not 
consistently related to age or height. Most importantly, the 
differences between the predicted values obtained were not 
always in the same direction (for example, the values 
obtained using the first equation were lower than those 
obtained using the second). Different combinations of 
age and height gave predicted values which were higher or 
lower in one equation than in the other (Table 6). 
COMPARING THE LOWER LIMIT OF 
NORMAL OBTAINED USING 80% OF 
PREDICTED AS CRITERION 
For each of the obtained predicted values (for each 
individual and for each equation) 80% of predicted value 
was calculated. We then compared the actual value 
obtained for each subject with that predicted by each 
equation. The percentage of individuals who were over 
80% using one equation (‘normal’) and under 80% using 
another (‘abnormal’) was determined. For female FEVi, 
the greatest percentage of individuals whose classification 
was changed was found with the Morris and Knudson 
equations at 19.6%. For male FEVi, Morris and Crapo 
gave 25.0%. For female FVC, ECCS and Crapo gave 
32.1% and for male FVC, ECCS and Crapo gave 36.5% 
(Table 6). Differences were also observed in FEVi and FVC 
for other pairs of equations. The percentage of differences 
was accentuated in the group of patients over 60 years of 
age. In this group, the patients who changed classification 
often exceeded 40% (for example, male FVC for Knudson 
and Crapo gave 51.8%; female FVC for ECCS and 
Chemiack gave 57*4%, for ECCS and Crapo, 55.5% and 
for ECCS and Knudson gave 41.6%). 
COMPARING THE LOWER LIMIT OF 
NORMAL OBTAINED USING 90% 
CONFIDENCE INTERVAL AS CRITERION 
The 90% confidence interval of the predicted value was 
calculated for each of the obtained predicted values (for 
each individual and for each equation), determining the 
specific lower limit of normal for each equation. We then 
compared the actual value, obtained for each subject with 
that predicted by each equation. The percentage of 
individuals who were over lower limit of normal using 
one equation (‘normal’) and under lower limit of normal 
(‘abnormal’) using another was determined. Differences 
were even greater than those obtained using 80% of 
predicted as normality criterion. For female FEVi, the 
greatest percentages of individuals who changed classifica- 
tion (‘normal’ to ‘abnormal’) were found using the Morris 
and Crapo equations at 33*5%, and for male FEVi using 
the Morris and Crapo equations, at 38.3%. Other major 
differences for female FVC, ECCS and Crapo, gave 37*3%, 
and for male FVC, Knudson and Crapo gave 34.6% 
(Table 7). 
COMPARING CRITERIA FOR THE LOWER 
LIMIT OF NORMAL 
Once the lower limits of normal had been calculated for the 
Morris and Crapo equations using both criteria, the 
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TABLE 4. Predicted values for FEVi and FVC in men of 1.70 m height and women of 1.60 m height derived from different 
reference equations 
Age 
(years) Morris Cherniak 
FVC FEV, 
Crap0 Knudson ECCS Morris Cherniak Crap0 Knudson ECCS 
Men 
20 
30 
40 
50 
60 
70 
80 
Women 
20 
30 
40 
50 
60 
70 
80 
5.17 4.63 5.11 4.96 4.93 4.25 4.13 4.35 4.20 4.14 
4.92 4.49 4.90 4.66 4.67 3.92 3.90 4.11 3.91 3.83 
4.67 4.35 4.69 4.36 4.41 3.60 3.67 3.87 3.62 3.52 
4.42 4.21 4.48 4.06 4.15 3.29 344 3.63 3.33 3.21 
4.17 4.07 4.27 3.76 3.89 2.97 3.21 3.39 3.04 2.90 
3.92 3.93 4.06 3.46 3.63 2.65 2-98 3.15 2.75 2.59 
3.67 3.19 3.85 3.16 3.37 2.33 2.75 2.91 2.48 2.28 
3.91 3.58 3.84 3.57 3.83 3.17 3.23 3.40 3.44 3.64 
3.67 3.43 3.625 3.40 3.56 2.92 3.04 3.14 3.24 3.33 
3.43 3.28 3.405 3.23 3.29 2.67 2.85 2.88 3.04 3,02 
3.19 3.13 3.18 3.06 3.02 2.42 2.66 2.62 2.84 2.71 
2.95 2.98 2.96 2.89 2.75 2,17 2.46 2.36 2.64 2.40 
2.71 2.83 2.74 2.72 2.48 1.92 2.28 2.10 244 2.09 
2.47 2.68 2.52 2.55 2.21 1.67 2.00 l-84 2.24 1.78 
percentage of tests in which 90% confidence interval value 
was under 80% of the predicted value was determined. 
Those tests would had been classified as ‘abnormal’ using 
the criterion of 80% of predicted value but not by the 90% 
confidence interval. The results are shown in Table 8. The 
value obtained from 90% confidence interval expressed as a 
percentage of predicted value showed a correlation with age 
(r=0.6&0*81) and with height (r= 0.43-0.72). The differ- 
ences between both definitions of normality become more 
noticeable in the group over 70 years of age (for example, 
using Morris’s equation the value of the 90% confidence 
interval was ~60% of the predicted value in 23.9% of male 
FEVi) (Table 9). 
Discussion 
The results of this study show that the clinical influence of 
the choice of a certain reference equation is important, 
because up to 40% of spirometric tests may change their 
clinical category (from ‘normal’ to ‘abnormal’) simply by 
changing the equation used. In the same way, defining the 
lower limit of normal 80% of the predicted value classifies 
as under the reference values an important number of cases 
which are classified as within the values when the 90% 
confidence interval is used as the defining criterion. 
Despite the large number of published reference equa- 
tion, in practice only a few are widely used. In the USA, the 
Morris, Crapo and Knudson equations are the most 
frequently used (14). In Argentina, there seems to be a 
similar distribution, with the addition of the ECCS and 
occasionally the Intermountain Thoracic Society (ITS) 
equations with the advent of computerized spirometers, 
the equations available in the software accompanying the 
equipment have great influence over choice. Even within 
this subgroup of equations, both the reference group and 
the conditions under which the studies were performed are 
different. It is usual to infer from those differences that the 
predicted values obtained may not be the same. The results 
from the present study show that the magnitude of such 
differences is quantitatively important. When the predicted 
values obtained by each equation are compared with the 
predicted values obtained using the Morris equation 
the means of differences show clinically relevant values 
(Table 5). 
The differences between these equations can be explained 
by diverse mechanisms. The ethnic composition of the 
samples is different. There is evidence that different ethnic 
groups have different lung volumes (3,15-17). Generally, 
reference equations obtained from white populations over- 
estimate the values for the black population in about 12% 
of subjects. The reason for this difference is not clear, but it 
can partly be related to different build (18). Other 
environmental differences related to physical activity, 
exposure to pollution or socioeconomic factors can 
contribute to these differences. Whether these differences 
exist in racial groups which are closer to one another is 
unknown, but possible. Other important differences be- 
tween the equations could derive from geographical factors, 
the percentage of manual or sedentary activity workers, 
different socioeconomic compositions or an urban versus a 
rural population, The adverse effects of unfavourable 
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TABLE 5. Means of differences* between predicted values using different equations 
Mean 
difference 
(4 (1) 
FEVi male FEVi female 
Standard Limits of Mean Standard Limits of 
deviation agreement difference deviation agreement 
(SD) (1) (d+ 1.96 SD) (1) (4 (1) (SD) (1) (d+ 1.96 SD) (1) 
Morris/Cherniack 0.19 0.16 0.50 0.25 0.13 o-50 
Morris/Crap0 0.39 0.21 0.80 0.19 0.01 0.20 
Morris/Knudson 0.10 0.24 0.57 0.12 0.09 0.29 
Morris/ECCS 0.10 0.08 0.25 0.04 0.02 0.07 
Mean 
difference 
(4 (1) 
FVC male FVC female 
Standard Limits of Mean Standard Limits of 
deviation agreement difference deviation agreement 
6”) (1) (dk 1.96 SD) (1) (4 (1) (SD) (1) (d+ 1.96 SD) (1) 
Morris/Cherniack 0.00 0.22 0.43 -0.17 0.20 0.56 
Morris/Crap0 -0.01 0.03 0.06 0.08 0.07 0.21 
Morris/Knudson -0.12 0.12 0.35 - 0.34 0.21 0.75 
Morris/ECCS - 0.30 0.03 0.35 -0.28 0.01 0.29 
*Mean of differences is mean for whole sample of predicted values from second equation - predicted value from Morris. 
Limits of agreements express the magnitude of difference which may be found in 95% of the population. So, differences 
between predicted values calculated by different equations may reach values up 0.50 1 as in male FEVt for Morris/Cherniak, 
Morris/Crap0 and Morris/Knudson, female FEV, for Morris/Cherniak or female FVC for Morris/Cherniak and Morris/ 
Knudson. 
socioeconomic conditions upon lung function have been 
well documented (19-21). The variation produced by 
circadian rhythm or by the different technical conditions 
used when registering values can also result in slight but 
relevant differences in the predicted values calculated (4). 
The magnitude of the differences among the equations 
shown by our data clearly suggest that is inappropriate to 
establish comparisons among study populations whose 
severity of obstruction or restriction have been classified as 
a percentage of predicted value according to different 
reference equations. Even though 80% of predicted value 
may not have been used as the ‘normality’ criterion, 
evaluation of the severity of impairment is usually 
performed using some percentage of the predicted value. 
This is mainly applied in the interpretation of clinical trials 
in which the degree of spirometric impairment is relevant. 
What then, is the importance of these differences to daily 
clinical practice? Despite the recommendations of the 
American College of Chest Physicians (ACCP) and ECCS, 
determining the lower limit of normal using 80% of 
predicted value is a frequent practice in most pulmonary 
laboratories. Our data show that the reference equation 
used when 80% of predicted is used as the reference range 
criterion can generate important differences in the defini- 
tion of ‘normality’ in both variables (FEVi and FVC) and 
in both sexes (Table 7). In a non-selected population, one- 
third or more of the subjects (depending on the reference 
equation) will be classified as abnormal simply due to the 
equation chosen. This difference becomes more significant 
in patients over 60 years of age, which includes half of the 
population. 
The observed differences among the definitions of 
‘normality’ using different equations and 80% of predicted 
value might be related to the use of each equation 
independently of its specific confidence interval. However, 
the differences are still apparent when the lower limit of 
normality is established using the 90% confidence interval. 
This confirms the remarkable practical difference among 
the available reference equations. 
We did not study a ‘normal’ population; we studied a 
patient population. We have therefore not tried to define 
which equation is the more sensitive or specific in 
identifying ‘abnormal’ subjects, but only to determine the 
proportion of patients in clinical practice who could be 
affected by changing the reference equation used. Although 
the importance of selecting appropriate reference equations 
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TABLE 7. Percentage of tests which change their definition (from ‘normal’ to ‘abnormal’) upon changing reference equation 
using 80% of predicted as the cut-off point 
FVC male (% of tests) FVC female (% of tests) 
Normals* Normals* Normals* Normals* Normals* Normals* 
by Morris by Knudson by ECCS by Morris by Knudson by ECCS 
(n=142) (n=205) (n=202) (n=229) (n=244) (n=299) 
Abnormals** by Cherniak 
Abnormals ** by Crapo 
Abnormals ** by Knudson 
Abnormals** by ECCS 
Abnormals ** by Morris 
0 19 14.8 10.9 10.6 26.1 
0 36.6 35.6 3.0 17.2 32.1 
9.2 5.4 11.3 - 18.4 
0 5.8 - 0 0 - 
- 31.2 30.2 - 9.0 23.4 
FEV, male (% of tests) 
Normals* Normals* 
by Morris by Knudson 
(n= 148) (n= 147) 
FEVi female (% of tests) 
Normals* Normals* 
by Morris by Knudson 
(n=242) (n=207) 
Abnormals ** by Cherniak 
Abnormals ** by Crapo 
Abnormals ** by Knudson 
Abnormals** by ECCS 
Abnormals ** by Morris 
13.5 13.9 0 0 
25.0 24.3 13.7 8.3 
8.1 - 19.6 - 
6.7 7.6 4.2 1.4 
6.2 0 
* > 80% of predicted. 
** < 80% of predicted. 
has been long recognized, the clinical consequences of this 
choice have not been fully examined. Harber et al. (22) 
studied the impact of reference equation selection on 
definition of ‘disability’ and concluded that the choice of 
prediction equation had minor effects. However, they only 
compared the Morris, Knudson and Kory equations for 
FEV,. In our study, for male FEV, the Morris and 
Knudson equations showed the lowest difference of the 
American equations. Importantly, when Harber et al. 
showed their ‘small’ differences (FEVi <60%, 32.3% of 
the sample using the Knudson equation 31.6% using the 
Morris equation) they were considering the global number 
of patients classified as ‘impaired’ as a percentage of the 
whole population and therefore did not consider how many 
of them had been individually classified in a different way 
by one or the other equation. In fact, using the same 
approach we would have found that the global amount of 
‘abnormals’ given by Knudson’s equation was not very 
different from that obtained from Morris’s equation 
(Tables 1 and 2). However, some of those ‘abnormal’ 
patients were not classified in the same way using the other 
prediction equation (Tables 7 and 8). One equation will give 
higher or lower values than the other for different 
combinations of age and height, as can be clearly seen in 
Table 6. Therefore, when we considered the proportion of 
‘normals’ from one equation (Morris) who were classed 
‘abnormal’ using the other (Knudson), the magnitude of 
the difference increased (8.1%). Additionally, the differ- 
ences were greater for other pairs of equations, other values 
(male FVC or female FEVi and, unexpectedly, when the 
90% confidence interval was used as the cut-off point. In 
the same way Shaffer et al. (23) in New Mexico found 
smaller differences comparing a locally derived equation for 
Hispanic population with ‘non-Hispanic’ equations (those 
of Knudson, Crapo and Dockery) because they also 
considered the percentage of patients classified as ‘normal’ 
for each equation but did not discriminate how many of 
those ‘abnormals’ were different individuals using one or 
the other equation. Our data show that this approach 
underestimates the actual differences among reference 
equations because it does not take into account the fact 
that those differences can be of a different direction (higher 
or lower than the compared equation), thus masking the 
real differences in classification for each individual subject. 
The last consideration involves the definition of the lower 
limit of normal. There is much theoretical evidence that the 
use of 80% (or any tixed percentage) of the predicted value 
is an incorrect criterion of classification (11,24). The 
spirometric values are derived from a regression equation. 
The dispersion of the data is then represented by the 
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TABLE 8. Percentage of tests which change their definition (from ‘normal’ to ‘abnormal’) upon changing reference equation 
using 90% confidence interval as the cut-off point 
FVC male (% of tests) FVC female (% of tests) 
Normals* Normals* Normals* Normals* Normals* Normals* 
by Morris by Knudson by ECCS by Morris by Knudson by ECCS 
(n=211) (Yl=252) (n=225) (n=296) (n=305) (n=332) 
Abnormals ** by Crapo 22.3 34.9 27.1 29.7 31.8 37.3 
Abnormals** by Knudson 1.9 - 3.1 2.0 - 9.0 
Abnormals** by ECCS 0 13.5 - 0 0.9 - 
Abnormals ** by Morris - 21.2 6.2 - 4.9 10.8 
FEVi male (% of tests) 
Normals* Normals* Normals* 
by Morris by Knudson by ECCS 
(n=185) (n=183) (n=165) 
FEVi female (% of tests) 
Normals* Normals* Normals* 
by Morris by Knudson by ECCS 
(n=304) (n=252) (n=265) 
Abnormals** by Crapo 38.3 37.1 30.9 33.5 19.8 23.3 
Abnormals** by Knudson 9.1 - 1.8 17.1 6.7 
Abnormals** by ECCS 11.8 10.9 13.1 2.4 - 
Abnormals ** by Morris - 7.6 1.2 - 0 0 
* <Lower limit of normal determined by 90% confidence interval. 
** > Lower limit of normal determined by 90% confidence interval. 
TABLE 9. Comparison between the lower limit or normal determined by the 90% confidence interval vs 80% of predicted value 
CI-LLN** 
(“/ of predicted) 
FEVi male (% of tests) 
Morris* Crapo* 
FEVi female (% of tests) 
Morris* Crapo* 
<80% 97.8% 82.7% 100% 64.0% 
< 70% 38.7% 2.2% 67.2% 5.2% 
<60% 4.2% 0% 19.8% 0% 
< 50% 0.4% 0% 2.8% 0% 
CI-LLN** 
(Oh of predicted) 
FVC male (% of tests) 
Morris* Crapo* 
FVC female (% of tests) 
Morris* Crapo* 
< 80% 100% 90.8% 98.0% 53.9% 
<70% 31.3% 4.0% 33.0% 0% 
<60% 0.4% 0% 2.0% 0% 
< 50% 0% 0% 0% 0% 
*Percentage of tests in which CI-LLN is below a certain percentage of predicted. 
**CI-LLN=lower limit of normal value defined by 90% confidence interval (predicted value - 1.64 SEE) using Morris and 
Crapo equations expressed as a percentage of predicted value. Each row represents the percentage of tests whose lower limit of 
normal calculated by mean of confidence interval is under a certain percentage of predicted value. For example using the 
Morris equation in 38.2% of tests FEVi lower limit of normal calculated by confidence interval is under 70% of predicted 
value. 
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standard error of the estimate (SEE) of that regression 
formula. The normal limits (from a statistic point of view) 
are defined by determining the 95% confidence interval by 
subtracting or adding 1.96 SEE. In this way it is assumed 
that 95% of the population will be within those values and 
therefore that only 5% will be incorrectly classified as 
‘abnormal’ (25). As the higher values are not relevant in 
spirometric testing, the 5% error can only be transferred to 
one end of the curve and, in this way, the confidence 
interval can be calculated at 90%, using 1.64 SEE. For 
spirometric values the dispersion of the data around the 
regression line is constant along the abscissa (for age and 
height), therefore the distribution is homoscedastic (11,25). 
This means that the deviation from the predicted values will 
be relatively higher for low values (i.e. in. short or old 
individuals) than for high values (26). The proposed 
alternative for calculating the lower limit of the normal 
range is determining the lower 95th percentile (5,27). This 
non-parametric cut-off has the advantage of not requir- 
ing a Gaussian distribution of data. However, in clinical 
practice, this method cannot be used with some equations 
(for example, the Morris or Crapo equations) which do 
not provide the values required. In fact, a non-parametric 
test would be very useful for clinical measures which are 
not normally distributed such as forced elipiratory from 
(FEF) 25-75% but this is not the subject of our clinical 
analysis. 
Therefore, although one must accept that the - 1.64 SEE 
criterion has some pitfalls (e.g. a reduced sensitivity for 
detecting abnormal subjects at older ages or at very low 
predicted values) (5), it is a reasonable and practical 
statistical cut-off point (11,24). In view of this, we decided 
to calculate the proportion of patients whose 90% 
confidence interval value (a legitimate statistical approach) 
was below 80% of their predicted value (an extended 
practical approach) using two well-recognized equations 
(Morris and Crapo). We did not aim to estimate the 
sensitivity, specificity or predicted value of each equation or 
of each method in defining normality, but only to show 
whether the classification of the subject would change by 
changing the reference equation or by using 80% of 
predicted or 90% confidence interval as the lower limit 
criterion. We did not try to define which equation gave the 
best results for our population as we wished to demonstrate 
that in any population it is important to validate the 
equation used and to calculate the 90% confidence interval 
as many subjects can be misclassified by using an 
inadequate equation or 80% of predicted as the lower limit 
criterion. 
Our data demonstrate that, in a non-selected clinical 
population, misclassification is very frequent and for a high 
percentage of the patients the ‘true’ lower limit of normal 
(determined by the 90% confidence interval) is below 80% 
of the predicted value. This phenomenon, as expected, is 
enormously emphasized in the older population and with 
the use of Morris’s equation (30% of men and 66% women 
have a 90% confidence interval below 70% of the predicted 
value). These patients would all have been misclassified as 
‘abnormal’ when they are actually included in the statistical 
range of data dispersion. 
In summary, the results of this study emphasize the 
importance of appropriate selection of the reference 
equation and its ratification with a sample of normal 
subjects in each laboratory. Furthermore, the use of a fixed 
percentage of the predicted value is not considered an 
acceptable definition of the lower limit of the normal range 
because of the large number of patients classified inappro- 
priately when this criterion is used. 
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